{
  "id": 16118022,
  "title": "Second-Season RSV Immunization Worked for Eligible Children",
  "url": "https://urgent.news/2026/10/22/second-season-rsv-immunization-worked-for-eligible-children",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-22T21:06:30.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/meetingcoverage/idweek/123536"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- WASHINGTON -- Real-world data backed the effectiveness of second-season nirsevimab (Beyfortus) immunizations against hospitalizations for children at high risk for severe respiratory syncytial virus (RSV) illness. In the case...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}